SMIP-34

N/A

Report date: 2024/12/20 15:58:09
NME

Base Information

Drug NameSMIP-34
Drug Alias NameSMIP34SMIP-34
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProline, Glutamate And Leucine Rich Protein 1 inhibitors
TargetsProline, Glutamate And Leucine Rich Protein 1
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Health Science Center San Antonio
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Health Science Center San Antonio
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A